Morgan Stanley’s Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share SGHC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,000
Closed -$7K 8037
2022
Q3
$7K Hold
10,000
﹤0.01% 7196
2022
Q2
$6K Hold
10,000
﹤0.01% 7381
2022
Q1
$29K Buy
+10,000
New +$17.5K ﹤0.01% 6985

Morgan Stanley's SGHC.WS Position: Q4 2022 in Review

Morgan Stanley sold out of Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share (SGHC.WS) in Q4 2022, closing a stake of 10,000 shares — an estimated $7K sold.

Morgan Stanley first reported a position in SGHC.WS in Q1 2022 and held it in 3 quarters. The position peaked at $29K in Q1 2022. 0 funds tracked by Wall St. Rank hold SGHC.WS as of Q4 2022.

  • Morgan Stanley reported no remaining Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share position as of Q4 2022 after selling out during the quarter.
  • Morgan Stanley sold 10,000 Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share shares in Q4 2022, an estimated $7K.
  • Morgan Stanley first reported a position in Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share in Q1 2022 and held it in 3 quarters.
  • Morgan Stanley's Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share position peaked at $29K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Super Group (SGHC) Limited Redeemable Warrants, each whole Warrant exercisable for one Ordinary Share, each at an exercise price of $11. 50 per share as of Q4 2022.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.